Tsutomu Nakagawa
Director/Miembro de la Junta en SUMITOMO PHARMA CO., LTD. .
Cargos activos de Tsutomu Nakagawa
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| SUMITOMO PHARMA CO., LTD. | Director/Miembro de la Junta | 25/06/2024 | - |
| Corporate Officer/Principal | 01/04/2016 | - | |
Sumitomo Pharma America, Inc.
 Sumitomo Pharma America, Inc. Pharmaceuticals: MajorHealth Technology Sumitomo Pharma America, Inc. operates as a biopharmaceutical company that develops pharmaceutical products. Its products include Aptiom (eslicarbazepine acetate) tablets, Latuda (lurasidone HCl) tablets, Lunesta (eszopiclone) tablets, Xopenex (levalbuterol HCl) Inhalation Solution, Xopenex HFA (levalbuterol tartrate) Inhalation Aerosol, Brovana (arformoterol tartrate) Inhalation Solution, Omnaris (ciclesonide) Nasal Spray, Alvesco (ciclesonide) Inhalation Aerosol, and Zetonna (ciclesonide) Nasal Aerosol. The company was founded in 1984 and is headquartered in Marlborough, MA. | Director/Miembro de la Junta | 01/07/2023 | - |
| Director Ejecutivo | 01/04/2024 | - | |
| Presidente | 01/04/2024 | - | |
| Corporate Officer/Principal | 01/07/2023 | 01/04/2024 |
Historial de carrera de Tsutomu Nakagawa
Estadísticas
Internacional
| Estados Unidos | 2 |
| Japón | 2 |
Operativa
| Director/Board Member | 2 |
| Corporate Officer/Principal | 2 |
| Chief Executive Officer | 1 |
Sectorial
| Health Technology | 3 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| SUMITOMO PHARMA CO., LTD. | Health Technology |
| Empresas privadas | 1 |
|---|---|
Sumitomo Pharma America, Inc.
Sumitomo Pharma America, Inc. Pharmaceuticals: MajorHealth Technology Sumitomo Pharma America, Inc. operates as a biopharmaceutical company that develops pharmaceutical products. Its products include Aptiom (eslicarbazepine acetate) tablets, Latuda (lurasidone HCl) tablets, Lunesta (eszopiclone) tablets, Xopenex (levalbuterol HCl) Inhalation Solution, Xopenex HFA (levalbuterol tartrate) Inhalation Aerosol, Brovana (arformoterol tartrate) Inhalation Solution, Omnaris (ciclesonide) Nasal Spray, Alvesco (ciclesonide) Inhalation Aerosol, and Zetonna (ciclesonide) Nasal Aerosol. The company was founded in 1984 and is headquartered in Marlborough, MA. | Health Technology |
- Bolsa de valores
- Insiders
- Tsutomu Nakagawa
- Experiencia
